The invention relates to a synthesis method of medroxyprogesterone acetate intermediate impurities. The intermediate
impurity is prepared by adding (8R, 9S, 10R, 13S, 14S, 17R)-17-acetyl-10, 13-dimethyl-6-
methylene-3-oxo-2, 3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17-tetradecahydro-1H-cyclopenta [a]
phenanthrene-17-acetate (B),
paraformaldehyde and a specific salt catalyst into a
solvent and carrying out a reaction. The high-purity medroxyprogesterone acetate intermediate
impurity (8R, 9S, 10R, 13S, 14S, 17R)-17-acetyl-10, 13-dimethyl-2, 6-dimethylene-3-oxo-2, 3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17-tetradecahydro-1H-cyclopenta [a]
phenanthrene-17-
ethyl formate (C) can be prepared by the synthesis method disclosed by the invention, and the
impurity can be used for qualitative and
quantitative determination of corresponding impurities in a medroxyprogesterone acetate intermediate and a
bulk drug thereof. The characterization of the quality of the medroxyprogesterone acetate
bulk drug is facilitated. The impurity synthesis
route is simple to operate, the yield is high, and the purity of the obtained impurity is high.